US Corporate Board Director Changes SEC Filings — July 08, 2026

08-07-2026

NioCorp Developments Ltd. adopted a formal annual incentive program (AIP) on July 2, 2026, and approved fiscal 2026 AIP payouts for named executive officers, including CEO Mark A. Smith ($602,784), CFO Neal S. Shah ($345,621), and COO Scott Honan ($378,197). The AIP is designed to attract, retain, and align employee interests with shareholders as the company advances its Elk Creek Project. Notably, no cash bonuses were paid to named executive officers for fiscal 2025, highlighting a shift to a performance-based compensation structure.

• · The AIP was adopted on recommendation of the Compensation Committee after a multi-month review with independent consultant Semler Brossy.
• · Award payouts range from 0% to 200% of target based on performance against pre-established measures.
• · For fiscal 2026, performance was weighted 45% corporate milestones, 10% safety, and 45% individual performance.
• · CEO Mark A. Smith's payout is paid to 76 Resources, LLC under a consulting arrangement.
• · No cash bonuses were paid to named executive officers for fiscal 2025.

08-07-2026

Courtney Mather resigned from the Board of Directors of Caesars Entertainment, Inc. effective July 6, 2026. The resignation was not due to any disagreement with the company. No financial impact or other operational changes were disclosed.

• · Resignation effective July 6, 2026.
• · No disagreement with the company cited as reason for departure.

08-07-2026

Internet Sciences, Inc. appointed Keith R. Wyche to its Board of Directors effective July 1, 2026. Mr. Wyche brings over two decades of leadership experience from Walmart, Cub Foods, Acme Markets, IBM, Pitney Bowes, and Convergys, and currently serves on the board of The Brink's Company. The appointment was ratified by majority shareholders.

• · Keith R. Wyche is a retired Vice President, Community Engagement and Support at Walmart Inc.
• · He previously served as President of Cub Foods and Acme Markets.
• · He currently serves on the board of The Brink's Company (NYSE: BCO).
• · The appointment was ratified by written consent of the majority shareholders.

08-07-2026

Moderna appointed Michael McDonnell, former CFO of Biogen, to its Board of Directors effective July 8, 2026. McDonnell brings over 35 years of financial leadership and public company experience, and will also serve on the Audit Committee. The appointment is a routine governance update with no financial impact disclosed.

• · McDonnell served as EVP and CFO of Biogen from August 2020 through February 2025.
• · Since March 2025, he has been an advisor to Goldman Sachs Asset Management.
• · He currently serves on the boards of Merit Medical Systems (Audit Committee chair) and Baxter International.
• · He began his career at PricewaterhouseCoopers, spending 14 years including four as a partner.

08-07-2026

Ovid Therapeutics announced the departure of Jeffrey Rona as Chief Business and Financial Officer, effective July 6, 2026, and appointed Charles Carter as CFO. The transition was mutual and not due to any disagreement. Carter brings experience from CERo Therapeutics and other life sciences firms, with a compensation package including a $460,000 base salary and equity grants.

• · Charles Carter, age 59, previously served as SVP of Finance at Ovid from October 2024 to July 2026.
• · Carter's prior roles include CFO at CERo Therapeutics (Feb 2024-Sep 2024), where he helped launch the company post de-SPAC.
• · Carter holds a BS from Colgate University and an MBA/MS from University of Chicago.
• · Rona's consulting agreement runs through December 31, 2027, with continued equity vesting during that period.
• · No family relationships or transactions requiring disclosure under Regulation S-K were identified for Carter.

08-07-2026

HF Sinclair Corporation announced leadership changes, appointing Steven Ledbetter as President and COO and Valerie Pompa as President of Growth, Technology and Transformation. CEO Franklin Myers will continue on a temporary basis, while Matthew Joyce remains in his role reporting directly to the CEO. The changes aim to sharpen execution and drive long-term value creation, but no financial metrics or performance data were provided.

• · Steven Ledbetter previously served as EVP, Commercial since March 2023; prior roles include CEO of Shell Midstream Partners GP LLC and CEO of Jiffy Lube International.
• · Valerie Pompa previously served as EVP, Operations since March 2023; prior roles include SVP, Refining Operations and owner/CEO of VAP Business Solutions Limited.
• · Matthew Joyce will continue as SVP, Lubricants & Specialties, reporting directly to CEO Franklin Myers, as the Lubricants & Specialties segment is considered distinct with its own growth priorities.
• · HF Sinclair operates refineries in Kansas, Oklahoma, New Mexico, Wyoming, Washington, and Utah, and produces renewable diesel at two Wyoming facilities and one New Mexico facility.

08-07-2026

Aura Biosciences announced the appointment of Jeremy Bender, Ph.D., M.B.A., to its Board of Directors. Dr. Bender brings extensive late-stage development and commercialization experience, having previously led Day One Biopharmaceuticals through its acquisition by Servier for approximately $2.5 billion. The company is advancing its lead candidate bel-sar toward potential regulatory approval for early choroidal melanoma, with enrollment complete in the Phase 3 CoMpass trial.

• · Dr. Bender most recently served as CEO, President, and board member of Day One Biopharmaceuticals, leading its acquisition by Servier for ~$2.5B in 2026.
• · He previously served as Vice President of Corporate Development at Gilead Sciences and held executive roles at Tizona Therapeutics, Sutro Biopharma, and Allos Therapeutics.
• · Dr. Bender currently serves as an independent board member of Mereo BioPharma Group plc and previously served on the board of Fusion Pharmaceuticals.
• · He earned a B.S. from Stanford, a Ph.D. from the University of Colorado, and an M.B.A. from MIT Sloan.
• · Aura's lead candidate bel-sar is in late-stage development for early choroidal melanoma and early-stage development for other ocular oncology indications and bladder cancer.

08-07-2026

Dravica Corp announced executive and board changes effective July 3, 2026: Robert Damian Szubanski resigned as Treasurer, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer (remaining President), and Varinia-Rebecca Undine Marie-Anne Koenig resigned as Secretary (remaining a Board member). Radek Chovanec, age 31, was appointed to fill all those vacated roles plus as a Director, bringing experience as Executive Director of M.B. Trade s.r.o. and a degree in Marketing Communications. The changes represent a consolidation of key officer positions into one individual; no financial metrics were disclosed.

• · Radek Chovanec has served as Executive Director of M.B. Trade s.r.o. since March 8, 2022.
• · Mr. Chovanec earned a degree in Marketing Communications from Tomas Bata University in Zlin, Czech Republic.
• · No family relationships, material transactions, or arrangements leading to Mr. Chovanec’s appointment were reported.
• · The company is an emerging growth company and has elected not to use the extended transition period for new accounting standards.

08-07-2026

Power REIT appointed Brent Morrison as an independent trustee on July 6, 2026. Mr. Morrison brings experience as Chairman, CEO, and President of Regional Health Properties, Inc., and will receive standard non-employee trustee compensation. No other financial metrics or period comparisons are provided in this filing.

• · Mr. Morrison will serve until the next annual meeting of shareholders or until his earlier resignation, retirement, or removal.
• · The Board determined Mr. Morrison satisfies NYSE American independence requirements.
• · No arrangements or understandings exist between Mr. Morrison and any other person regarding his appointment.
• · No transactions involving Mr. Morrison require disclosure under Item 404(a) of Regulation S-K.

08-07-2026

Ultra Clean Holdings, Inc. (UCTT) announced the appointment of Michael Keogh as Chief Financial Officer, effective August 5, 2026, succeeding Sheri Savage. Keogh brings over 25 years of financial and operational leadership from Ford, Apple, Intel, and other firms, and will report to CEO James Xiao. The appointment is part of the company's UCT 3.0 strategy execution.

• · Keogh previously served as CFO of Ford Model e and Integrated Services, shaping Ford's EV strategy and supporting multi-billion-dollar joint ventures.
• · He led the financial turnaround at Bright Machines as CFO.
• · Earlier roles include senior finance leadership at Apple, Stanley Black & Decker, and Intel.
• · Keogh holds an MBA from Cornell University and a BA in Industrial Relations from UNC Chapel Hill.

08-07-2026

MacroGenics, Inc. (MGNX) announced that board member Dr. Karen Ferrante has resigned for personal reasons, effective September 1, 2026. Her departure is not due to any disagreement with the company's operations, policies, or practices.

08-07-2026

Longeveron Inc. issued special equity awards to its Executive Chairman on July 6, 2026, consisting of 500,000 RSUs for his role in the March 2026 financing transaction and an additional 100,000 RSUs plus 400,000 non-qualified stock options for continued service. All awards vest quarterly over three years starting October 1, 2026, and convert into Class B Common Stock (5 votes per share), which is convertible to Class A Common Stock. No financial results or period-over-period comparisons are provided in this filing.

• · The Executive Chairman (not named in filing) received the awards.
• · Class B Common Stock has 5 votes per share vs. Class A Common Stock's 1 vote per share.
• · Class B Common Stock is convertible at any time at the holder's option into Class A Common Stock.
• · The awards were approved by the Company's Compensation Committee.

08-07-2026

Alamo Group Inc. announced the appointment of Greg Lucas as Vice President, Corporate Controller and Chief Accounting Officer, effective on or before August 10, 2026. He will replace Agnes Kamps as principal accounting officer, while Ms. Kamps remains Executive Vice President and CFO. Mr. Lucas brings experience from Thermon Group, BNSF Railway, and Intertek, and will receive an annual base salary of $335,000 plus equity awards and incentive plan participation.

• · Mr. Lucas's employment is contingent upon passing pre-employment screenings.
• · No related party transactions were disclosed between Mr. Lucas and the Company.
• · Mr. Lucas holds a BBA in Accounting and Economics from East Texas Baptist University and an MBA from Texas A&M University.

08-07-2026

Seres Therapeutics held its reconvened 2026 Annual Meeting on July 8, 2026, where stockholders approved all five proposals, including the election of three Class II directors, ratification of PricewaterhouseCoopers as auditor, advisory approval of executive compensation, and an amendment to the 2025 Incentive Award Plan to increase authorized shares by 900,000. The meeting had a quorum of 4,985,176 shares (51.75% of outstanding stock), but the relatively high number of votes against or withheld on several proposals indicates some shareholder dissent.

• · The meeting had been adjourned from June 9, 2026 due to lack of quorum.
• · Broker non-votes totaled 868,715 on all proposals except the auditor ratification (which had 0 broker non-votes).
• · Proposal 3 (advisory say-on-pay) received 3,374,813 FOR, 620,353 AGAINST, and 121,295 abstentions – a notable 15.5% against vote.
• · Proposal 4 (plan amendment) passed with 3,438,763 FOR vs. 597,484 AGAINST (14.8% against).
• · Proposal 5 (adjournment) was approved but not needed since Proposal 4 passed.

08-07-2026

Spectral AI, Inc. announced the hiring of Darcy L. Bajko as Chief Commercial Officer, effective July 31, 2026, with an annual salary of $315,000 and eligibility for a discretionary bonus of up to 30% of salary. The offer also includes a 401(k) match and an option grant of 150,000 common shares vesting over three years. No departures or financial results were disclosed; the filing solely covers a new executive appointment.

• · Start date of new CCO is July 31, 2026, pending background check.
• · Payroll is processed on the 3rd and 20th of each month.
• · 401(k) plan eligibility begins after three months of employment with dollar-for-dollar match up to 6% of base salary.
• · Option grant of 150,000 common shares vests annually over three years; pricing set on date of Board approval.
• · Paid time off accrues at 10 hours per month (15 days annually) with only 120 hours carryover per year.
• · Employment is at-will; either party may terminate at any time without notice or severance.
• · Confidentiality, non-compete, and proprietary rights agreement (Exhibit A) is attached and must be executed as a condition of employment.

08-07-2026

First Bancorp, Inc. (FNLC) announced the retirement of Tammy Plummer, Executive Vice President and Chief Information Officer, after a 41-year career at First National Bank. Brad Martin has been appointed as her successor, bringing over 17 years of financial services experience, most recently as SVP, Director of IT at another Maine-based institution. The transition is planned to ensure continuity, with no financial impact disclosed.

• · Tammy Plummer started as a Teller in 1985 and held roles including Data Processing Manager (1994), CTO (2003), CIO (2014), and EVP/CIO (2015).
• · Brad Martin most recently served as Senior Vice President, Director of Information Technology at another Maine-based financial institution.
• · The filing was made under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers).

08-07-2026

NAPCO Security Technologies announced an executive leadership transition effective July 8, 2026: founder Richard Soloway moves from CEO to Executive Chairman, and President/COO Kevin Buchel becomes CEO and President. The change is intended to position the company for its next phase of growth, with Soloway remaining Chairman and focusing on strategic initiatives and innovation.

• · Richard Soloway founded NAPCO more than 55 years ago
• · Kevin Buchel has been with NAPCO for more than 25 years and served as President and COO for two years
• · The press release contains forward-looking statements regarding the transition and the Company's ability to increase revenue and profitability

08-07-2026

Seritage Growth Properties entered into an amended and restated employment agreement with CEO Adam Metz on July 1, 2026, extending his term for an initial six months with a company option to extend another six months. The agreement increases his target annual bonus from $1,225,000 to $1,300,000 while maintaining his base salary at $1,100,000. The filing reflects a short-term retention arrangement with a modest bonus increase, but no other financial or operational changes were disclosed.

• · Employment agreement has an initial term of six months with a company option to extend for an additional six months.
• · If the extension option is not exercised, the bonus performance period is prorated to six months with a target of 50% of the full Target Bonus ($650,000).
• · No other changes were made to the terms and conditions of the employment agreement beyond the bonus increase and term structure.
• · The filing does not include any financial results, operational updates, or changes to the board of directors.

08-07-2026

374Water Inc. appointed Charles Weiser as CFO effective July 1, 2026, with an annual base salary of $225,000 (deferred until September 1, 2026), a $25,000 signing bonus, and equity grants of 150,000 stock options and 125,000 RSUs. Concurrently, Interim CFO Adrienne Anderson resigned but will continue providing financial consulting services. The appointment fills a key leadership role, though the salary deferral and bonus contingency on capitalization signal ongoing cash constraints.

• · Charles Weiser, age 67, has been a board member since December 29, 2025, and will continue on the board while serving as CFO.
• · Weiser's base salary will not commence until September 1, 2026; no salary for July 1 – August 31, 2026.
• · The $25,000 signing bonus accrues July 1, 2026, but is payable only when the Company is properly capitalized.
• · Equity grants: 25% vest immediately on grant date; remaining 75% vest in 12 equal quarterly installments starting October 1, 2026.
• · Upon a change of control, 50% of unvested equity vests immediately; if terminated without cause or resignation for good reason within 12 months post-change, all remaining unvested shares vest.
• · Severance includes 6 months base salary, continued health coverage, pro-rated bonus, and 6 months accelerated equity vesting.
• · Adrienne Anderson resigned as Interim CFO effective July 1, 2026, but will continue providing consulting services on SEC reporting, compliance, and corporate finance.

08-07-2026

BellRing Brands (NYSE:BRBR) announced the appointment of Michael Axelrod as its next President and CEO, effective July 29, 2026, succeeding Darcy Davenport who is retiring. Axelrod brings over 30 years of CPG experience, most recently as CEO of Snak King, and will also join the Board of Directors. The company reported over $2.3 billion in sales under Davenport's tenure, but faces the challenge of maintaining growth momentum amid strong consumer demand for protein, with Premier Protein holding the #1 ready-to-drink protein brand position.

• · Axelrod will also be appointed to the company's Board of Directors.
• · Davenport will stay on in a senior advisory capacity to ensure a smooth transition.
• · Axelrod holds an honors bachelor's degree from University of Western Ontario Ivey Business School and an MBA from Northwestern University Kellogg School of Management.
• · The company's brands are distributed in over 90 countries across club, mass, food, eCommerce, specialty, drug and convenience channels.

08-07-2026

Customers Bancorp, Inc. entered into a new Supplemental Executive Retirement Plan (SERP) for Lyle Cunningham on July 8, 2026, replacing a prior plan from April 2022. The plan provides a monthly lifetime benefit of $12,500 upon retirement after normal retirement age, along with early termination, change-in-control, disability, and death benefits, and includes clawback, noncompete, and forfeiture provisions.

• · The Plan supersedes a prior Supplemental Executive Retirement Plan adopted on April 27, 2022.
• · The Plan is intended to be unfunded and primarily for a select group of management or highly compensated employees under ERISA, and compliant with Section 409A of the Internal Revenue Code.
• · No financial impact or performance metrics were disclosed in this filing.

08-07-2026

Copart Inc. announced the promotion of Jane Pocock to President, effective August 1, 2026. Ms. Pocock, who joined Copart in 2019 as Managing Director of Copart UK, has led significant growth and operational expansion in the UK and Ireland. The filing highlights her leadership in strengthening customer experience and technology-enabled services, but provides no financial metrics or performance comparisons for the current period.

• · Jane Pocock joined Copart in January 2019 as Managing Director of Copart UK.
• · Prior to Copart, Ms. Pocock was Chief Executive of Vans Direct.
• · Copart operates in 11 countries with over 250 locations.
• · Copart sold more than 4 million units in the last year.
• · Copart has approximately 1 million members in over 185 countries.

08-07-2026

Catalyst Pharmaceuticals stockholders voted overwhelmingly to approve the merger with Angelini Pharma S.p.A., with 97,340,180 votes for and 1,143,815 against, representing approval by holders of more than a majority of outstanding shares. However, a non-binding advisory vote on executive compensation related to the merger was not approved (30,504,686 for, 67,486,884 against), though this does not affect the merger's completion. In connection with the merger, all seven current directors have indicated their intention to resign effective at the closing of the transaction.

• · The merger proposal was approved by holders of more than a majority of Catalyst's outstanding common shares, satisfying one of the closing conditions under the Merger Agreement.
• · The adjournment proposal was not voted upon because sufficient votes were present to approve the merger.
• · All seven directors' resignations are conditioned upon and effective as of the effective time of the merger and are not due to any disagreement with the Company.

08-07-2026

GMR Solutions Inc. announced the appointments of Dr. Amar Desai and Ellen Zane to its Board of Directors, effective July 1, 2026. The appointments bring expertise in healthcare transformation, value-based care, governance, and workforce leadership, completing the Board as the company advances its long-term strategy. No financial metrics or period-over-period comparisons were provided in this filing.

• · Dr. Desai will serve on the Nominating, Corporate Governance and Compliance Committee.
• · Ellen Zane will serve as Chair of the Human Capital and Compensation Committee.
• · GMR operates in approximately 1,400 counties across the U.S., serving more than 60% of the population.
• · GMR supports roughly 5.5 million patient encounters annually and performs a critical care intervention every 88 seconds.
• · The company has roughly 34,000 team members.

08-07-2026

Hyperion DeFi, Inc. (HYPD) entered into new employment agreements with CEO Hyunsu Jung, CFO David Knox, and General Counsel Robert Rubenstein, effective July 7, 2026, to standardize executive terms and align with industry best practices. The agreements enhance severance benefits, including change-in-control protections and accelerated equity vesting, while setting new bonus targets (up to 75% of base salary for Knox, 35% for Rubenstein) and a base salary of $325,000 for Rubenstein. No financial results or period-over-period comparisons are included in this filing.

• · The new employment agreements were effective July 7, 2026.
• · CEO Jung's agreement adds a change-in-control severance payment equal to his target bonus, in addition to previously disclosed severance benefits.
• · CFO Knox and GC Rubenstein receive 12 months of base salary and health benefits upon qualifying termination, plus a target bonus payment if termination occurs within 12 months of a change in control.
• · All three executives will have time- or service-based vesting conditions on equity awards deemed satisfied upon a change in control while employed.
• · Knox's bonus target is up to 75% of base salary; Rubenstein's is up to 35% of base salary.
• · Rubenstein's base salary is set at $325,000 (no prior salary disclosed for comparison).

08-07-2026

On July 1, 2026, Gemaxel Inc. (formerly WORLDS INC) appointed Matthew Toboroff to its Board of Directors to fill a vacancy created by the passing of Thom Kidrin. Matthew Toboroff is the son of Leonard Toboroff, who serves as the company's Interim CEO and a Director. The filing contains no financial data or performance metrics.

• · Matthew Toboroff was appointed effective July 1, 2026.
• · The vacancy was created by the passing of Thom Kidrin.
• · Matthew Toboroff's father, Leonard Toboroff, is the Interim CEO and a Director.

08-07-2026

Old Second Bancorp Inc. announced the resignation of Director John Williams, Jr., effective July 7, 2026, pursuant to the company's Director Resignation Policy requiring directors to resign upon reaching age 73. The resignation is not due to any disagreement with the company. The board will not immediately fill the vacancy and will reduce its size by one member.

• · John Williams, Jr. served on the Risk and Insurance Committee.
• · He had been a board member since 2021.
• · The board intends to maintain board classes as nearly equal in number as possible after the reduction.

08-07-2026

Blue Chip Capital Group Inc. appointed John E. Driscoll, 60, as Co-Chief Operating Officer effective July 5, 2026. Mr. Driscoll, a CFE and CIA, brings extensive experience from prior roles including CFO at multiple companies, Chief Audit Executive at Finastra Corporation, and forensic accountant with the New York County DA's office. The filing contains only the appointment announcement with no financial data or performance metrics, limiting materiality.

• · Mr. Driscoll served as a consultant to Blue Chip Capital Group since December 2024 before his appointment as Co-COO.
• · Prior to this role, from 2023 to 2024, he was CFO of Gipefi Cosmetics/Ustawi.
• · From 2022 to 2023 he served as CFO and Board Member of Grellner Media.
• · From 2021 to 2022 he was EVP and CFO of New You, Inc./ST Brands.
• · He holds an M.S. in Economics from Syracuse University and a B.S. in Finance and Accounting from St. John's University.